Register for AllyCon 2024
Join us for a three-day experience where patients, caregivers, and advocates unite against colorectal cancer. Register by October 14 for early bird pricing.
Colorectal cancer is one of the most common cancers in both men and women. Surgery is the main treatment for colorectal cancer, especially for patients diagnosed in the early stages. During surgery, part of the colon and sometimes rectum that has the tumor is removed, along with some of the nearby healthy tissue and lymph nodes.
Colorectal tumors can be removed through open surgery, where a surgeon makes one large cut in the abdomen (10-25 cm) to reach the colon. Now there are new and less invasive surgical procedures that are improving safety and recovery time.
Laparoscopic surgery is a type of minimally invasive surgery where the surgeon uses several small cuts in the abdomen (0.5-1 cm) to insert surgical instruments, including a long and thin tube with a light and a camera on the end called a laparoscope. A larger cut, about 3-5 cm wide, is made to remove the cancerous part of the colon or rectum. The laparoscope shows images on video monitors in the operating room. During the operation, the surgeon moves the instruments by watching the monitors.
Robotic surgery is a newer type of laparoscopic surgery. In this procedure, the surgeon makes several small cuts in the abdomen. A camera and other surgical instruments are placed in this procedure too, but in robotic surgery, the surgeon controls the instruments using a computer. The camera sends 3D images to a high-definition computer monitor.
The treatment option is for patients with KRASG12C-mutated locally advanced or metastatic colorectal cancer (CRC) who have received prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.
Statistics suggested that Christy’s odds of survival were grim, so she leaned into her faith and kept a positive outlook. She tried to control what she could. And, critically, she received biomarker testing.
The EPIC Act would encourage investment in clinical trials for additional uses of existing drugs.